Most of the patients with chronic obstructive pulmonary disease (COPD) or pulmonary fibrosis needs pulmonary rehabilitation to keep airway clear.
Some physicians recommend handheld oscillatory positive expiratory pressure (OPEP) devices for patients with stable COPD to remove secretions. These devices require patients to exhale against a fluctuating resistance.
If handheld devices are ineffective, the patient moves to a vest, which delivers high frequency chest wall oscillation (HFCWO).
- The Vest Airway Clearance System
The Vest Airway Clearance System is designed to assist patients in the mobilization of retained secretions. If not removed, retained secretions may contribute to increased rates of respiratory infection, hospitalization, and reduced lung function.
Through HFCWO technology, The Vest Airway Clearance System dislodges mucus from the bronchial walls and mobilizes secretions and mucus from the smaller to larger airways where it can be cleared by coughing or suctioning.
- Philips InCourage System
InCourage system can help break the serious cycle of excess mucus, lung infections and further lung damage for patients living with chronic respiratory conditions.
Patients who use vest therapy have been shown to experience fewer pneumonias, fewer hospitalizations, and better results on pulmonary function tests, which measure how well the lungs are working.
- The Monarch Airway Clearance System
This airway clearance therapy helps thin mucus and increase airflow, mobilizing secretions from the airways while you are going about your day. As a result, you no longer have to put your life on hold for therapy.
- AffloVest
AffloVest is a proven HFCWO therapy designed to provide patients the freedom and mobility to customize and enhance airway clearance therapy, help mobilize lung secretions, and promote treatment adherence for patients with bronchiectasis, cystic fibrosis, COPD,MS, MD (muscular dystrophy), ALS, and other neuromuscular and respiratory diseases.
AffloVest has eight mechanical oscillating motors scientifically engineered to target all 5 lobes of the lungs, front and back, for full mobility during use. With no bulky hoses or generators, the AffloVest is engineered to encourage treatment adherence and compliance by allowing patients to experience an improved quality of life during airway clearance treatments.
The AffloVest has received the FDA’s 510k clearance for U.S. market availability, and is approved for Medicare, Medicaid, and private health insurance reimbursement.
References:
- respiratorytherapy.ca
- hill-rom.com
- cegla-shop.com
- haag-streit.com
- medline.com
- trudellmed.com
- philips.com
- mymonarch.com
- bronchiectasis.com.au
- hindawi.com
- merckmanuals.com
- lung.org
- cff.org
